Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00318292 · ClinicalTrials.gov registry record · Phase 4

Preemptive Local Anesthesia in Vaginal Surgery

A Phase 4 study of Pain, Postoperative, sponsored by Mayo Clinic.

Completed
Registry status
Phase 4
Development phase
90
Enrollment target
1
Study location

NCT00318292 is a Phase 4 study of Pain, Postoperative that has completed, run by Mayo Clinic. The registered enrollment target is 90 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00318292, a Phase 4 study of Pain, Postoperative, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 4
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Preemptive analgesia is an intervention which provides an anesthetic prior to initiating a painful stimulus. This trial is examining the effects of a local anesthetic given at the point of innervation prior to performing a vaginal hysterectomy with suspension sutures.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG bupivacaine and epinephrine

Study Locations (1)

Arizona

  • Mayo Clinic - Scottsdale

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2006-04
Est. Completion 2008-03
Phase Phase 4

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT00318292

The ClinicalTrials.gov registry entry for NCT00318292 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (67% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00318292 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT00318292 about?

NCT00318292 is a clinical study titled "Preemptive Local Anesthesia in Vaginal Surgery". Preemptive analgesia is an intervention which provides an anesthetic prior to initiating a painful stimulus. This trial is examining the effects of a local anesthetic given at the point of innervation prior to performing a vaginal hysterectomy with suspension sutures.

What is the current status of trial NCT00318292?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2006-04. Estimated completion is 2008-03.

What conditions does trial NCT00318292 study?

This clinical trial studies the following conditions: Pain, Postoperative.

What interventions are being tested in trial NCT00318292?

The interventions under investigation include: Placebo (DRUG), bupivacaine and epinephrine (DRUG).

Who is sponsoring clinical trial NCT00318292?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00318292 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.